The Splicing Regulator Rbfox2 Is Required for Both Cerebellar Development and Mature Motor Function
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Regulation of Pluripotency by RNA Binding Proteins
Cell Stem Cell Review Regulation of Pluripotency by RNA Binding Proteins Julia Ye1,2 and Robert Blelloch1,2,* 1The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Center for Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA 2Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.stem.2014.08.010 Establishment, maintenance, and exit from pluripotency require precise coordination of a cell’s molecular machinery. Substantial headway has been made in deciphering many aspects of this elaborate system, particularly with respect to epigenetics, transcription, and noncoding RNAs. Less attention has been paid to posttranscriptional regulatory processes such as alternative splicing, RNA processing and modification, nuclear export, regulation of transcript stability, and translation. Here, we introduce the RNA binding proteins that enable the posttranscriptional regulation of gene expression, summarizing current and ongoing research on their roles at different regulatory points and discussing how they help script the fate of pluripotent stem cells. Introduction RBPs are responsible for every event in the life of an RNA Embryonic stem cells (ESCs), which are derived from the inner molecule, including its capping, splicing, cleavage, nontem- cell mass of the mammalian blastocyst, are remarkable because plated nucleotide addition, nucleotide editing, nuclear export, they can propagate in vitro indefinitely while retaining both the cellular localization, stability, and translation (Keene, 2007). molecular identity and the pluripotent properties of the peri-im- Overall, little is known about RBPs: most are classified based plantation epiblast. -
RBM9 Antibody (Monoclonal) (M02) Mouse Monoclonal Antibody Raised Against a Partial Recombinant RBM9
10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 RBM9 Antibody (monoclonal) (M02) Mouse monoclonal antibody raised against a partial recombinant RBM9. Catalog # AT3594a Specification RBM9 Antibody (monoclonal) (M02) - Product Information Application IF, WB, E Primary Accession O43251 Other Accession BC013115 Reactivity Human, Mouse Host mouse Clonality Monoclonal Isotype IgG2b Kappa Calculated MW 41374 RBM9 Antibody (monoclonal) (M02) - Additional Information Immunofluorescence of monoclonal antibody to RBM9 on A-431 cell. [antibody concentration 10 ug/ml] Gene ID 23543 Other Names RNA binding protein fox-1 homolog 2, Fox-1 homolog B, Hexaribonucleotide-binding protein 2, RNA-binding motif protein 9, RNA-binding protein 9, Repressor of tamoxifen transcriptional activity, RBFOX2, FOX2, HRNBP2, RBM9, RTA Target/Specificity RBM9 (AAH13115, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Dilution Antibody Reactive Against Recombinant WB~~1:500~1000 Protein.Western Blot detection against Immunogen (36.63 KDa) . Format Clear, colorless solution in phosphate buffered saline, pH 7.2 . Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Precautions RBM9 Antibody (monoclonal) (M02) is for research use only and not for use in diagnostic or therapeutic procedures. Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 RBM9 Antibody (monoclonal) (M02) - Protocols Provided below are standard protocols that you may find useful for product applications. • Western Blot • Blocking Peptides • Dot Blot • Immunohistochemistry • Immunofluorescence • Immunoprecipitation • Flow Cytomety RBM9 monoclonal antibody (M02), clone • Cell Culture 5E11 Western Blot analysis of RBM9 expression in A-431 ( (Cat # AT3594a ) RBM9 monoclonal antibody (M02), clone 5E11. -
Downloads/ (Accessed on 17 January 2020)
cells Review Novel Approaches for Identifying the Molecular Background of Schizophrenia Arkadiy K. Golov 1,2,*, Nikolay V. Kondratyev 1 , George P. Kostyuk 3 and Vera E. Golimbet 1 1 Mental Health Research Center, 34 Kashirskoye shosse, 115522 Moscow, Russian; [email protected] (N.V.K.); [email protected] (V.E.G.) 2 Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilova Street, 119334 Moscow, Russian 3 Alekseev Psychiatric Clinical Hospital No. 1, 2 Zagorodnoye shosse, 115191 Moscow, Russian; [email protected] * Correspondence: [email protected] Received: 5 November 2019; Accepted: 16 January 2020; Published: 18 January 2020 Abstract: Recent advances in psychiatric genetics have led to the discovery of dozens of genomic loci associated with schizophrenia. However, a gap exists between the detection of genetic associations and understanding the underlying molecular mechanisms. This review describes the basic approaches used in the so-called post-GWAS studies to generate biological interpretation of the existing population genetic data, including both molecular (creation and analysis of knockout animals, exploration of the transcriptional effects of common variants in human brain cells) and computational (fine-mapping of causal variability, gene set enrichment analysis, partitioned heritability analysis) methods. The results of the crucial studies, in which these approaches were used to uncover the molecular and neurobiological basis of the disease, are also reported. Keywords: schizophrenia; GWAS; causal genetic variants; enhancers; brain epigenomics; genome/epigenome editing 1. Introduction Schizophrenia is a severe mental illness that affects between 0.5% and 0.7% of the human population [1]. Both environmental and genetic factors are thought to be involved in its pathogenesis, with genetic factors playing a key role in disease risk, as the heritability of schizophrenia is estimated to be 70–85% [2,3]. -
The Splicing Factor RNA-Binding Fox Protein 1 Mediates the Cellular Immune Response in Drosophila Melanogaster
The Splicing Factor RNA-Binding Fox Protein 1 Mediates the Cellular Immune Response in Drosophila melanogaster This information is current as Ashley E. Nazario-Toole, Javier Robalino, Kwame Okrah, of September 27, 2021. Hector Corrada-Bravo, Stephen M. Mount and Louisa P. Wu J Immunol published online 11 July 2018 http://www.jimmunol.org/content/early/2018/07/10/jimmun ol.1800496 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2018/07/10/jimmunol.180049 Material 6.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 11, 2018, doi:10.4049/jimmunol.1800496 The Journal of Immunology The Splicing Factor RNA-Binding Fox Protein 1 Mediates the Cellular Immune Response in Drosophila melanogaster Ashley E. Nazario-Toole,*,† Javier Robalino,* Kwame Okrah,‡ Hector Corrada-Bravo,‡ Stephen M. Mount,*,‡ and Louisa P. -
Generalised Anxiety Disorder – a Twin Study of Genetic Architecture, Genome-Wide Association and Differential Gene Expression
RESEARCH ARTICLE Generalised Anxiety Disorder – A Twin Study of Genetic Architecture, Genome-Wide Association and Differential Gene Expression Matthew N. Davies1,2☯*, Serena Verdi1☯, Andrea Burri1, Maciej Trzaskowski3, Minyoung Lee4, John M. Hettema4, Rick Jansen5, Dorret I. Boomsma6, Tim D. Spector1 1 Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom, 2 Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom, 3 Social Genetic & Developmental Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom, 4 Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, United States of America, 5 Department of Biological Psychology, VU University Amsterdam, Neuroscience Campus, Amsterdam, the Netherlands, 6 Department of Psychiatry, VU University Medical Center, Neuroscience Campus, Amsterdam, the Netherlands ☯ These authors contributed equally to this work. * [email protected] OPEN ACCESS Citation: Davies MN, Verdi S, Burri A, Trzaskowski M, Lee M, Hettema JM, et al. (2015) Generalised Abstract Anxiety Disorder – A Twin Study of Genetic Architecture, Genome-Wide Association and Generalised Anxiety Disorder (GAD) is a common anxiety-related diagnosis, affecting Differential Gene Expression. PLoS ONE 10(8): approximately 5% of the adult population. One characteristic of GAD is a high degree of e0134865. doi:10.1371/journal.pone.0134865 anxiety sensitivity (AS), a personality trait which describes the fear of arousal-related sensa- Editor: Valerie W Hu, The George Washington tions. Here we present a genome-wide association study of AS using a cohort of 730 MZ University, UNITED STATES and DZ female twins. -
Genetic Variants and Prostate Cancer Risk: Candidate Replication and Exploration of Viral Restriction Genes
2137 Genetic Variants and Prostate Cancer Risk: Candidate Replication and Exploration of Viral Restriction Genes Joan P. Breyer,1 Kate M. McReynolds,1 Brian L. Yaspan,2 Kevin M. Bradley,1 William D. Dupont,3 and Jeffrey R. Smith1,2,4 Departments of 1Medicine, 2Cancer Biology, and 3Biostatistics, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine; and 4Medical Research Service, VA Tennessee Valley Healthcare System, Nashville, Tennessee Abstract The genetic variants underlying the strong heritable at genome-wide association study loci 8q24, 11q13, and À À component ofprostate cancer remain largely unknown. 2p15 (P =2.9Â 10 4 to P =4.7Â 10 5), showing study Genome-wide association studies ofprostate cancer population power. We also find evidence to support have yielded several variants that have significantly reported associations at candidate genes RNASEL, replicated across studies, predominantly in cases EZH2, and NKX3-1 (P = 0.031 to P = 0.0085). We unselected for family history of prostate cancer. further explore a set of candidate genes related to Additional candidate gene variants have also been RNASEL and to its role in retroviral restriction, proposed, many evaluated within familial prostate identifying nominal associations at XPR1 and RBM9. cancer study populations. Such variants hold great The effects at 8q24 seem more pronounced for those potential value for risk stratification, particularly for diagnosed at an early age, whereas at 2p15 and early-onset or aggressive prostate cancer, given the RNASEL the effects were more pronounced at a later comorbidities associated with current therapies. Here, age. However, these trends did not reach statistical we investigate a Caucasian study population of523 significance. -
C. Elegans GFP/RFP Alternative Splicing Screen
ARTICLES Transgenic alternative-splicing reporters reveal tissue-specific expression profiles and regulation s d mechanisms in vivo o h t e 1,2 3,4 3,4 1,2 m Hidehito Kuroyanagi , Tetsuo Kobayashi , Shohei Mitani & Masatoshi Hagiwara e r u t a n / Alternative splicing of pre-mRNAs allows multicellular organisms native exons have been well characterized by analyzing model genes. m o c to create a huge diversity of proteomes from a finite number of Expression cloning strategies have permitted the global collection . e r genes. But extensive studies in vitro or in cultured cells have not of putative sequence elements that function in cultured cells, and u t a fully explained the regulation mechanisms of tissue-specific or bioinformatic analyses have identified putative cis elements within n . developmentally regulated alternative splicing in living exons and introns. Recently, however, conditional knockouts of w w organisms. Here we report a transgenic reporter system that trans-acting SR protein families revealed that alternative splicing of w / / : allows visualization of expression profiles of mutually exclusive only a few target genes are crucially dependent on a specific protein p t t exons in Caenorhabditis elegans. Reporters for egl-15 exons 5A in cardiac muscles, even though many more genes expressed in this h and 5B showed tissue-specific profiles, and we isolated mutants 14 p tissue have typical cis elements . This indicates that we cannot u o defective in the tissue specificity. We identified alternative- precisely predict the alternative splicing patterns in each tissue r G splicing defective-1 (asd-1), encoding a new RNA-binding or cell without the assessment of the regulation mechanisms in g protein of the evolutionarily conserved Fox-1 family, as a living organisms. -
The Splicing Regulator Rbfox1 (A2BP1) Controls Neuronal Excitation in the Mammalian Brain
LETTERS The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain Lauren T Gehman1, Peter Stoilov2, Jamie Maguire3, Andrey Damianov4, Chia-Ho Lin4, Lily Shiue5, Manuel Ares Jr5, Istvan Mody6,7 & Douglas L Black1,4,8 The Rbfox family of RNA binding proteins regulates alternative The three mouse Rbfox paralogues show a high degree of sequence splicing of many important neuronal transcripts, but its role in conservation, especially within the RNA binding domain, which is neuronal physiology is not clear1. We show here that central identical in Rbfox1 and Rbfox2 and is only slightly altered in Rbfox3 nervous system–specific deletion of the gene encoding Rbfox1 (94% amino acid identity). Rbfox1 is specifically expressed in neurons, results in heightened susceptibility to spontaneous and kainic heart and muscle6,18, whereas Rbfox2 is expressed in these tissues acid–induced seizures. Electrophysiological recording revealed and in other cell types, including the embryo, hematopoetic cells and a corresponding increase in neuronal excitability in the dentate embryonic stem cells6,19,20. Expression of Rbfox3 is limited to neu- gyrus of the knockout mice. Whole-transcriptome analyses rons21,22. In the mature brain, most neurons express all three Rbfox identified multiple splicing changes in the Rbfox1−/− brain with paralogs, but certain neuronal subtypes and sporadic individual cells few changes in overall transcript abundance. These splicing can be seen that express only one or two of the proteins23 (Fig. 1a). changes alter proteins that mediate synaptic transmission and All three proteins have similar N- and C-terminal domains that are membrane excitation. Thus, Rbfox1 directs a genetic program diversified by alternative promoter use and alternative splicing to required in the prevention of neuronal hyperexcitation and produce a cohort of related protein isoforms with variable localization seizures. -
RNA Splicing Regulated by RBFOX1 Is Essential for Cardiac Function in Zebrafish Karen S
© 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 3030-3040 doi:10.1242/jcs.166850 RESEARCH ARTICLE RNA splicing regulated by RBFOX1 is essential for cardiac function in zebrafish Karen S. Frese1,2,*, Benjamin Meder1,2,*, Andreas Keller3,4, Steffen Just5, Jan Haas1,2, Britta Vogel1,2, Simon Fischer1,2, Christina Backes4, Mark Matzas6, Doreen Köhler1, Vladimir Benes7, Hugo A. Katus1,2 and Wolfgang Rottbauer5,‡ ABSTRACT U2, U4, U5 and U6) and several hundred associated regulator Alternative splicing is one of the major mechanisms through which proteins (Wahl et al., 2009). Some of the best-characterized the proteomic and functional diversity of eukaryotes is achieved. splicing regulators include the serine-arginine (SR)-rich family, However, the complex nature of the splicing machinery, its associated heterogeneous nuclear ribonucleoproteins (hnRNPs) proteins, and splicing regulators and the functional implications of alternatively the Nova1 and Nova2, and the PTB and nPTB (also known as spliced transcripts are only poorly understood. Here, we investigated PTBP1 and PTBP2) families (David and Manley, 2008; Gabut et al., the functional role of the splicing regulator rbfox1 in vivo using the 2008; Li et al., 2007; Matlin et al., 2005). The diversity in splicing is zebrafish as a model system. We found that loss of rbfox1 led to further increased by the location and nucleotide sequence of pre- progressive cardiac contractile dysfunction and heart failure. By using mRNA enhancer and silencer motifs that either promote or inhibit deep-transcriptome sequencing and quantitative real-time PCR, we splicing by the different regulators. Adding to this complexity, show that depletion of rbfox1 in zebrafish results in an altered isoform regulating motifs are very common throughout the genome, but are expression of several crucial target genes, such as actn3a and hug. -
RBFOX2 (N) Antibody, Rabbit Polyclonal
Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com RBFOX2 (N) Antibody, Rabbit Polyclonal Cat#: R1749-1 Lot#: Refer to vial Quantity: 100 ul Application: WB Predicted I Observed M.W.: 41 I 56 kDa Uniprot ID: O43251 Background: RNA binding protein fox-1 homolog 2 (RBFOX2) is an RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements and seems to act as a coregulatory factor of ER-alpha. RBFOX2 prevents binding of U2AF2 to the 3'-splice site. RBFOX2 regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis. Other Names: RNA binding protein fox-1 homolog 2, Fox-1 homolog B, Hexaribonucleotide-binding protein 2, RNA- binding motif protein 9, RNA-binding protein 9, Repressor of tamoxifen transcriptional activity, FOX2, HRNBP2, RBM9, RTA Source and Purity: Rabbit polyclonal antibodies were produced by immunizing animals with a GST-fusion protein containing the N-terminal region of human RBFOX2. Antibodies were purified by affinity purification using immunogen. Storage Buffer and Condition: Supplied in 1 x PBS (pH 7.4), 100 ug/ml BSA, 40% Glycerol, 0.01% NaN3. Store at -20 °C. Stable for 6 months from date of receipt. Species Specificity: Human Tested Applications: WB: 1:1,000-1:3,000 (detect endogenous protein*) *: The apparent protein size on WB may be different from the calculated M.W. due to modifications. For research use only. Not for therapeutic or diagnostic purposes. Abiocode, Inc., 29397 Agoura Rd., Ste 106, Agoura Hills, CA 91301 Order: (888)-282-5810 (Phone) (818)-707-0392 (Fax) [email protected] Web: www.Abiocode.com Product Data: kDa A B 175 80 58 46 30 25 Fig 1. -
Secondary Motifs Enable Concentration-Dependent Regulation
bioRxiv preprint doi: https://doi.org/10.1101/840272; this version posted November 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Secondary motifs enable concentration-dependent regulation by Rbfox family proteins 12 November 2019 Bridget E. Begg1, Marvin Jens1, Peter Y. Wang1, Christopher B. Burge1* 1Department of Biology Massachusetts Institute of Technology Cambridge MA 02139 * Correspondence: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/840272; this version posted November 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The Rbfox family of splicing factors regulate alternative splicing during animal development and in disease, impacting thousands of exons in the maturing brain, heart, and muscle. Rbfox proteins have long been known to bind to the RNA sequence GCAUG with high affinity, but just half of Rbfox CLIP peaks contain a GCAUG motif. We incubated recombinant RBFOX2 with over 60,000 transcriptomic sequences to reveal significant binding to several moderate-affinity, non-GCAYG sites at a physiologically relevant range of RBFOX concentrations. We find that many of these “secondary motifs” bind Rbfox robustly in vivo and that several together can exert regulation comparable to a GCAUG in a trichromatic splicing reporter assay. Furthermore, secondary motifs regulate RNA splicing in neuronal development and in neuronal subtypes where cellular Rbfox concentrations are highest, enabling a second wave of splicing changes as Rbfox levels increase. -
100002369.Pdf
“The Rbfox1 gene: expression analysis and study of the transcrip onal regula on” Disserta on zur Erlangung des Grades “Doktor der Naturwissenscha en” Am Fachbereich Biologie der Johannes Gutenberg-Universität Mainz Sònia Casanovas Palau geb. am 13.01.1982 in Reus-SPAIN Mainz 2018 Summary Summary The RBFOX1 gene, which is located on chromosome 16p13.2, encodes an RNA-binding protein that regulates pre-mRNA splicing events in specific cell types including neurons. In the mouse, the gene contains a large noncoding part in its 5' end with at least four alternative promoters, promoters 1B, 1C, 1D and 1E. Promoters 1B, 1C and 1D are brain specific and promoter 1E is muscle specific. The promoters drive the expression of the alternative Rbfox1 transcript isoforms, which differ in their 5'UTR but not in their coding exons. Copy number variants (CNVs) in the human RBFOX1 gene that are located in the 5'-noncoding part of the gene and that typically only affect some but not all RBFOX1 transcript isoforms, have been associated with a range of neurodevelopmental disorders such as autism spectrum disorder, intellectual disability, epilepsy, attention deficit hyperactivity disorder and schizophrenia. In this thesis, I analyzed the expression of the three brain-specific Rbfox1 transcript isoforms controlled by the promoters 1B, 1C and 1D during embryonic development of the cerebral cortex as well as in various brain regions of the juvenile mouse. Furthermore, through in silico analysis and luciferase assays, I characterized the alternative Rbfox1 promoters and demonstrated that the expression of Rbfox1 in primary cortical neurons is driven by promoters 1B and 1C.